Vinod Aera, Delphine Angole, Véronique Leblais, Grégoire Vandecasteele, Boris Manoury
{"title":"tnf - α抑制内皮细胞中camp介导的eNOS丝氨酸-633位点磷酸化","authors":"Vinod Aera, Delphine Angole, Véronique Leblais, Grégoire Vandecasteele, Boris Manoury","doi":"10.1016/j.acvd.2025.03.027","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>Inflammatory mechanisms are recognized as players in the pathophysiology of cardiovascular diseases. High levels of tumor necrosis factor-α (TNF-α) occur in heart failure leading to pleiotropic effects. In blood vessels, the second messenger cyclic-adenosine monophosphate (cAMP) mediates vasodilation, inhibits proliferation and improves barrier function. Also, cAMP participates in nitric oxide (NO) synthesis by promoting protein kinase A (PKA)-mediated phosphorylation of endothelial NO synthase (eNOS) at serine-633 (ser633-eNOS). Vascular dysfunction is a hallmark of heart failure, but how inflammatory cytokines influence vascular cAMP pathways is unclear.</div></div><div><h3>Objective</h3><div>The aim of this study is to examine the influence of TNF-α exposure on the cAMP pathway in endothelial cells.</div></div><div><h3>Method</h3><div>Human coronary artery endothelial cells (HCAEC) were cultured between passages 5 and 7. Sub-confluent HCAEC were exposed to TNF-α (10<!--> <!-->ng/mL) or vehicle. After 24<!--> <!-->h treatment, cells were stimulated for 30<!--> <!-->min with isoprenaline (1<!--> <!-->μM) or combination of forskolin analogue (L-858051, 30<!--> <!-->μM) and phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine (IBMX, 300<!--> <!-->μM) in order to stimulate cAMP production, or vehicle. Cells were then harvested in ice-cold lysis buffer and frozen. Cell lysates were processed for immunoblot studies. Signals obtained on phosphorylated sites in eNOS and vasodilator-stimulated phosphoprotein (VASP) were normalized to the respective signal obtained for total protein. Where relevant, protein level was normalized to GAPDH level.</div></div><div><h3>Results</h3><div>In control condition, L-858051 with IBMX stimulated the phosphorylation of ser633-eNOS and ser157-VASP significantly (<em>n</em> <!-->=<!--> <!-->4, <em>P</em> <!--><<!--> <!-->0.05). Cell exposure to TNF-α induced expression of intercellular adhesion molecule ICAM-1. TNF-α significantly decreased total eNOS expression compared to control condition (<em>P</em> <!--><<!--> <!-->0.05). Interestingly, TNF-α abolished the effect of L-858051 with IBMX on ser633-eNOS phosphorylation, but did not alter that of ser157-VASP (<em>P</em> <!--><<!--> <!-->0.05). Isoprenaline had no significant effect on any phosphorylation site.</div></div><div><h3>Conclusion</h3><div>Exposure of HCAEC to TNF-α decreased cAMP-related phosphorylation of eNOS while leaving intact the phosphorylation of VASP, a standard surrogate for PKA activation in vascular cells. Future experiments will investigate whether TNF-α diruspts specific cAMP signaling compartments in endothelial cells, which may participate to vascular dysfunction.</div></div>","PeriodicalId":55472,"journal":{"name":"Archives of Cardiovascular Diseases","volume":"118 6","pages":"Page S184"},"PeriodicalIF":2.3000,"publicationDate":"2025-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"TNF-alpha inhibits cAMP-mediated phosphorylation of eNOS at serine-633 in endothelial cells\",\"authors\":\"Vinod Aera, Delphine Angole, Véronique Leblais, Grégoire Vandecasteele, Boris Manoury\",\"doi\":\"10.1016/j.acvd.2025.03.027\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Introduction</h3><div>Inflammatory mechanisms are recognized as players in the pathophysiology of cardiovascular diseases. High levels of tumor necrosis factor-α (TNF-α) occur in heart failure leading to pleiotropic effects. In blood vessels, the second messenger cyclic-adenosine monophosphate (cAMP) mediates vasodilation, inhibits proliferation and improves barrier function. Also, cAMP participates in nitric oxide (NO) synthesis by promoting protein kinase A (PKA)-mediated phosphorylation of endothelial NO synthase (eNOS) at serine-633 (ser633-eNOS). Vascular dysfunction is a hallmark of heart failure, but how inflammatory cytokines influence vascular cAMP pathways is unclear.</div></div><div><h3>Objective</h3><div>The aim of this study is to examine the influence of TNF-α exposure on the cAMP pathway in endothelial cells.</div></div><div><h3>Method</h3><div>Human coronary artery endothelial cells (HCAEC) were cultured between passages 5 and 7. Sub-confluent HCAEC were exposed to TNF-α (10<!--> <!-->ng/mL) or vehicle. After 24<!--> <!-->h treatment, cells were stimulated for 30<!--> <!-->min with isoprenaline (1<!--> <!-->μM) or combination of forskolin analogue (L-858051, 30<!--> <!-->μM) and phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine (IBMX, 300<!--> <!-->μM) in order to stimulate cAMP production, or vehicle. Cells were then harvested in ice-cold lysis buffer and frozen. Cell lysates were processed for immunoblot studies. Signals obtained on phosphorylated sites in eNOS and vasodilator-stimulated phosphoprotein (VASP) were normalized to the respective signal obtained for total protein. Where relevant, protein level was normalized to GAPDH level.</div></div><div><h3>Results</h3><div>In control condition, L-858051 with IBMX stimulated the phosphorylation of ser633-eNOS and ser157-VASP significantly (<em>n</em> <!-->=<!--> <!-->4, <em>P</em> <!--><<!--> <!-->0.05). Cell exposure to TNF-α induced expression of intercellular adhesion molecule ICAM-1. TNF-α significantly decreased total eNOS expression compared to control condition (<em>P</em> <!--><<!--> <!-->0.05). Interestingly, TNF-α abolished the effect of L-858051 with IBMX on ser633-eNOS phosphorylation, but did not alter that of ser157-VASP (<em>P</em> <!--><<!--> <!-->0.05). Isoprenaline had no significant effect on any phosphorylation site.</div></div><div><h3>Conclusion</h3><div>Exposure of HCAEC to TNF-α decreased cAMP-related phosphorylation of eNOS while leaving intact the phosphorylation of VASP, a standard surrogate for PKA activation in vascular cells. Future experiments will investigate whether TNF-α diruspts specific cAMP signaling compartments in endothelial cells, which may participate to vascular dysfunction.</div></div>\",\"PeriodicalId\":55472,\"journal\":{\"name\":\"Archives of Cardiovascular Diseases\",\"volume\":\"118 6\",\"pages\":\"Page S184\"},\"PeriodicalIF\":2.3000,\"publicationDate\":\"2025-05-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Archives of Cardiovascular Diseases\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1875213625001226\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of Cardiovascular Diseases","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1875213625001226","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
TNF-alpha inhibits cAMP-mediated phosphorylation of eNOS at serine-633 in endothelial cells
Introduction
Inflammatory mechanisms are recognized as players in the pathophysiology of cardiovascular diseases. High levels of tumor necrosis factor-α (TNF-α) occur in heart failure leading to pleiotropic effects. In blood vessels, the second messenger cyclic-adenosine monophosphate (cAMP) mediates vasodilation, inhibits proliferation and improves barrier function. Also, cAMP participates in nitric oxide (NO) synthesis by promoting protein kinase A (PKA)-mediated phosphorylation of endothelial NO synthase (eNOS) at serine-633 (ser633-eNOS). Vascular dysfunction is a hallmark of heart failure, but how inflammatory cytokines influence vascular cAMP pathways is unclear.
Objective
The aim of this study is to examine the influence of TNF-α exposure on the cAMP pathway in endothelial cells.
Method
Human coronary artery endothelial cells (HCAEC) were cultured between passages 5 and 7. Sub-confluent HCAEC were exposed to TNF-α (10 ng/mL) or vehicle. After 24 h treatment, cells were stimulated for 30 min with isoprenaline (1 μM) or combination of forskolin analogue (L-858051, 30 μM) and phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine (IBMX, 300 μM) in order to stimulate cAMP production, or vehicle. Cells were then harvested in ice-cold lysis buffer and frozen. Cell lysates were processed for immunoblot studies. Signals obtained on phosphorylated sites in eNOS and vasodilator-stimulated phosphoprotein (VASP) were normalized to the respective signal obtained for total protein. Where relevant, protein level was normalized to GAPDH level.
Results
In control condition, L-858051 with IBMX stimulated the phosphorylation of ser633-eNOS and ser157-VASP significantly (n = 4, P < 0.05). Cell exposure to TNF-α induced expression of intercellular adhesion molecule ICAM-1. TNF-α significantly decreased total eNOS expression compared to control condition (P < 0.05). Interestingly, TNF-α abolished the effect of L-858051 with IBMX on ser633-eNOS phosphorylation, but did not alter that of ser157-VASP (P < 0.05). Isoprenaline had no significant effect on any phosphorylation site.
Conclusion
Exposure of HCAEC to TNF-α decreased cAMP-related phosphorylation of eNOS while leaving intact the phosphorylation of VASP, a standard surrogate for PKA activation in vascular cells. Future experiments will investigate whether TNF-α diruspts specific cAMP signaling compartments in endothelial cells, which may participate to vascular dysfunction.
期刊介绍:
The Journal publishes original peer-reviewed clinical and research articles, epidemiological studies, new methodological clinical approaches, review articles and editorials. Topics covered include coronary artery and valve diseases, interventional and pediatric cardiology, cardiovascular surgery, cardiomyopathy and heart failure, arrhythmias and stimulation, cardiovascular imaging, vascular medicine and hypertension, epidemiology and risk factors, and large multicenter studies. Archives of Cardiovascular Diseases also publishes abstracts of papers presented at the annual sessions of the Journées Européennes de la Société Française de Cardiologie and the guidelines edited by the French Society of Cardiology.